Aptamer Therapeutics Ltd – enabling drug discovery
Aptamer Therapeutics specialises in the development of nucleic acid aptamers to serve as drug delivery vehicles and Aptamer drug conjugates. The ability of aptamers to specifically target a protein, cell or tissue type; means that we can facilitate delivery of your payload to its site of action.
In addition to aptamer-based targeted delivery; we are developing aptamers for use as new aptamer-based therapies
Aptamers can be:
- Used directly as therapeutic agents
- Used to modulate the activity of a therapeutic agent